Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesCompumedics Ltd

Compumedics Ltd

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.24 AUD -0.01 ( 4.00%)
Last update at 2026-11-12T00:59:00Z
VOLUME
13700
Market Cap
45.95M

Momentum Score

…

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and associated technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. The company provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon HST; and Somté, an investigative tool. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG, Grael 4K-EEG, and Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Okti, a portable EEG amplifier; and Siesta 802, a multi-functional ambulatory recording device. In addition, it provides software products, such as Profusion Sleep software suite; Profusion EEG Software; Profusion neXus 360, a web-based patient data and lab management system that offers integrated hardware and software solutions for sleep and neurology clinics; CURRY, a signal processing and source localization multi-modal neuroimaging suite; Profusion neXus Scheduler for planning for staff and time; Somte and Persyst Software; HD Digital Video; Profusion Plus; ECG Free software; and TCM5 FLEX Transcutaneous Monitor, Grael DC, Siesta extended battery pack, and Summit IP products. Further, the company offers brain research technologies; pharmaceutical clinical trials and research services; and consumables and supplies for diagnostic and research solutions. The company was incorporated in 1987 and is headquartered in Abbotsford, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.24
Low
0.24
High
52 Week Price Range
0.21
Low
0.45
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Compumedics Ltd develops and sells diagnostic medical devices and software for sleep disorders and neurophysiology, serving hospitals, sleep clinics and research institutions. Long-term growth may be supported by rising diagnosis of sleep apnea, demographic trends, expansion in home testing and international market penetration. Investors may find the company attractive for its focused clinical product set, installed base and recurring software and service opportunities.

Primary risks include competition from larger medical-device companies, regulatory and reimbursement changes across markets, reliance on hospital procurement cycles and exposure to supply-chain and foreign-exchange fluctuations.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.25
Dividend Yield
-
Revenue TTM
61.88M
Revenue Per Share
0.31
Gross Profit TTM
32.64M
Debt / Equity
0.62
ROE
1.14%
Net Debt
7.96M
ROCE
6.28%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 1.66M -0.59M 0.48M -6.72M 1.70M
Net income 0.21M -1.27M -0.34M -6.12M 1.36M
Selling general administrative - 17.39M 7.08M 6.41M 5.64M
Selling and marketing expenses - 11.74M 14.06M 13.25M 9.48M
Gross profit 30.98M 30.99M 26.07M 21.59M 19.29M
Reconciled depreciation - - 1.57M 1.01M 1.21M
Ebit 1.79M 0.71M 1.22M -2.98M 2.10M
Ebitda 3.98M 1.94M 2.79M -1.97M 2.61M
Depreciation and amortization 2.20M 1.23M 1.57M 1.01M 0.51M
Operating income 1.79M 0.71M -0.81M -3.02M 0.99M
Other operating expenses 58.47M 50.33M 50.53M -7.35M 0.36M
Interest expense 1.51M 1.28M 0.74M 0.65M 0.40M
Tax provision - 0.86M 0.82M -0.60M 0.34M
Interest income - 1.31M 0.92M 0.61M 0.23M
Net interest income - - -0.74M -0.65M -0.40M
Income tax expense 1.45M 0.68M 0.82M -0.60M 0.34M
Total revenue 60.25M 51.04M 49.72M 42.41M 37.76M
Total operating expenses 29.19M 30.27M 26.88M 26.14M 19.69M
Cost of revenue 29.27M 20.05M 23.65M 20.82M 18.46M
Total other income expense net -0.12M -1.31M 1.29M -2.53M 1.99M
Net income from continuing ops - - -0.34M -6.12M 1.36M
Net income applicable to common shares - -1.27M -0.34M -6.12M 1.36M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 56.63M 54.39M 40.15M 41.18M 41.49M
Intangible assets - 16.59M - 6.24M 6.45M
Other current assets 1.85M 2.99M 0.71M 2.43M 2.35M
Total liab 33.92M 32.57M 22.13M 22.89M 17.90M
Total stockholder equity 22.71M 21.82M 18.02M 18.29M 23.59M
Deferred long term liab - - - 6.24M 6.45M
Other current liab 4.98M 6.74M 4.46M 4.26M 3.51M
Common stock 41.41M 39.45M 35.65M 35.65M 35.65M
Capital stock - - - 35.65M 35.65M
Retained earnings -18.37M -18.58M -17.47M -17.79M -11.67M
Other liab - - - 0.14M 0.20M
Other assets - - - 1.10M 6.95M
Cash 6.15M 2.69M 1.89M 3.80M 7.08M
Cash and equivalents - - - - 7.08M
Total current liabilities 28.18M 32.11M 21.22M 21.19M 17.32M
Current deferred revenue 5.73M - 1.34M 2.69M 1.92M
Net debt 7.96M 11.19M 6.68M 5.67M -0.75M
Short term debt 10.25M 13.70M 7.72M 7.91M 5.95M
Short long term debt - - - 7.22M 5.80M
Short long term debt total 14.11M 13.88M 8.56M 9.47M 6.33M
Other stockholder equity -0.34M - -0.17M -17.86M -23.98M
Property plant equipment - - - 3.62M 1.21M
Total current assets 34.64M 35.22M 25.95M 29.52M 33.33M
Long term investments - - - 0.70M -
Net tangible assets - - - 18.29M 23.59M
Net receivables 12.95M 14.88M 10.45M 12.53M 14.12M
Long term debt - - - 0.20M 0.38M
Inventory 13.69M 14.66M 12.91M 10.69M 9.71M
Accounts payable 7.22M 11.68M 7.70M 6.33M 5.94M
Accumulated other comprehensive income - 0.96M - 0.43M -0.39M
Non currrent assets other - 0.05M 10.16M - -1.21M
Non current assets total 21.99M 19.17M 14.20M 11.66M 8.16M
Capital lease obligations - - - 2.04M 0.15M
Long term debt total - - - 1.56M 0.38M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - - -2.99M -4.41M -2.96M
Change to liabilities - - - 0.49M 0.92M
Total cashflows from investing activities -3.90M -7.37M -2.99M -4.41M -2.96M
Net borrowings - - -0.95M -1.00M 1.28M
Total cash from financing activities 4.26M 6.10M -1.49M -1.00M 1.28M
Change to operating activities - - - 0.68M 0.52M
Net income 0.21M -1.27M -0.34M -6.12M 1.36M
Change in cash 3.46M -0.56M -2.57M -4.99M 1.94M
Begin period cash flow 2.69M -0.27M 2.30M 7.29M 5.14M
End period cash flow 6.15M -0.82M -0.27M 2.30M 7.08M
Total cash from operating activities 6.61M 0.68M 2.00M 0.05M 3.29M
Depreciation 2.20M 2.25M 1.57M 0.98M 1.13M
Other cashflows from investing activities - -7.16M -2.67M - -
Change to inventory 0.96M -1.45M -2.52M -0.98M -0.03M
Change to account receivables 1.93M -6.73M 3.82M 1.51M -0.99M
Other cashflows from financing activities -0.84M 3.20M -0.54M -0.14M 3.83M
Change to netincome - - - 3.37M 0.60M
Capital expenditures 0.18M 0.21M 2.99M 4.41M 2.96M
Change in working capital 5.09M -7.69M 1.55M 0.53M -1.02M
Other non cash items -0.90M 7.40M -0.78M 4.66M 1.81M
Free cash flow 6.42M 0.47M -0.99M -4.36M 0.33M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CMP
Compumedics Ltd		 -0.01
4.00%		 0.24 - 14.37 0.74 2.02 0.89 10.04
COH
Cochlear Ltd		 2.26
1.50%		 152.98 68.64 27.40 4.30 5.34 3.97 28.09
IMR
Imricor Medical Systems Inc		 0.06
4.72%		 1.33 - - 36401.21 17.45 4019.33 -2.60
AVR
Anteris Technologies Global Corp		 0.50
5.88%		 9.00 - - 356.02 2.19 130.34 -5.20
AVH
Avita Medical Inc		 -0.11
2.13%		 5.06 - 9.97 9.59 7.17 6.76 15.37

Profile*

Compumedics Ltd

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and associated technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. The company provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon HST; and Somté, an investigative tool. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG, Grael 4K-EEG, and Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Okti, a portable EEG amplifier; and Siesta 802, a multi-functional ambulatory recording device. In addition, it provides software products, such as Profusion Sleep software suite; Profusion EEG Software; Profusion neXus 360, a web-based patient data and lab management system that offers integrated hardware and software solutions for sleep and neurology clinics; CURRY, a signal processing and source localization multi-modal neuroimaging suite; Profusion neXus Scheduler for planning for staff and time; Somte and Persyst Software; HD Digital Video; Profusion Plus; ECG Free software; and TCM5 FLEX Transcutaneous Monitor, Grael DC, Siesta extended battery pack, and Summit IP products. Further, the company offers brain research technologies; pharmaceutical clinical trials and research services; and consumables and supplies for diagnostic and research solutions. The company was incorporated in 1987 and is headquartered in Abbotsford, Australia.

30-40 Flockhart Street, Abbotsford, VIC, Australia, 3067

61 3 8420 7300

https://www.compumedics.com.au

175

Name Title Year Born
Dr. David Burton Ph.D. Founder, Exec. Chairman, CEO & Member of Medical Advisory Board 1959
Mr. David Francis Lawson CFO, Company Sec. & Exec. Director 1965
Mr. Warwick Freeman Chief Technology Officer NA
Mr. Christoph Witte Gen. Managing of Director DWL Compumedics Germany GmbH NA
Dr. Kerry Trent Hubick Legal Counsel and Trademark, Patent & Gen. Legal Attorney NA
Dr. Curtis Ponton Chief Scientist of Neuroscan & VP NA
Mr. Paul Spooner Bus. Director of EMEA NA
Dr. David Burton Ph.D. Founder, Executive Chairman, CEO & Member of Medical Advisory Board 1959
Mr. David Francis Lawson CFO, Company Secretary & Executive Director 1965
Dr. Kerry Trent Hubick Legal Counsel and Trademark, Patent & General Legal Attorney NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…